How Your Thyroid Controls Your Testosterone (Check This Before TRT)

Your thyroid produces two hormones, but only one of them actually does anything.

T4, called thyroxine, makes up about 80% of what your thyroid gland releases into circulation. T3, called triiodothyronine, makes up the remaining 20%. T4 is the storage form, biologically inert until converted. T3 is the active form, the version that actually binds to receptors and drives metabolic function throughout your body. So the 80% that your thyroid produces in abundance is essentially raw material waiting to be processed, and the conversion happens outside the gland entirely.

That conversion is carried out by enzymes called deiodinases, which strip one iodine atom off the T4 molecule to produce active T3. These enzymes require selenium to function. When selenium is inadequate, the conversion rate drops and you end up with elevated T4 and low T3, meaning plenty of raw material and not enough finished product. Research published in BMC Endocrine Disorders confirmed this directly, showing that selenium deficiency is associated with a significantly higher free T4 to free T3 ratio, exactly the pattern you would predict if the processing step were impaired.

But conversion failure is only half the problem. There is also a competing pathway where T4 gets converted into something called reverse T3 instead of active T3, and reverse T3 is biologically inactive. It occupies the same receptors that active T3 would use, but it does not activate them, so it effectively blocks the signal. Chronic cortisol is the main driver of this diversion. Research by Chopra and colleagues showed that elevated cortisol shifts T4 metabolism away from active T3 and toward reverse T3 within hours of exposure. This is why chronic stress can produce functional hypothyroidism where your TSH looks completely normal because your thyroid gland is producing T4 just fine, but the downstream conversion is being redirected into an inactive dead end.

This matters because standard thyroid testing only measures TSH, and TSH only tells you what your brain is asking for, not what your tissues are actually receiving. A normal TSH tells you the feedback loop is intact. It tells you nothing about whether the T4 your thyroid is producing is being converted to active T3 or being shunted into reverse T3. You need free T3 and reverse T3 to answer that question, and most clinics never order them.

Now here is where this connects to testosterone, because the connection is direct and it runs through three separate mechanisms.

The first is at the pituitary. The system that drives testosterone production follows a relay: your hypothalamus releases something called GnRH, which signals your pituitary to release LH, which signals your testes to produce testosterone. T3, your active thyroid hormone, modulates how well your pituitary responds to that GnRH signal. In a hypothyroid state, the signal arrives but the pituitary produces an inadequate LH response, so the relay weakens before it ever reaches the testes. A 2000 study by Donnelly and White observed this exact pattern in men with primary hypothyroidism. Their free testosterone nearly doubled, from 161 to 315 pmol/L, after thyroxine replacement normalized their thyroid function, and the pattern was hypogonadotropic, meaning the failure was upstream in the signaling chain rather than in the testes themselves.

The second mechanism is at the Leydig cell, which is the cell in your testes that actually manufactures testosterone. Leydig cells have thyroid hormone receptors on them, and T3 binding to those receptors does two things. It increases the number of LH receptors on the cell surface, making the cell more sensitive to whatever LH signal it receives, and it upregulates something called StAR protein, which stands for steroidogenic acute regulatory protein. StAR is the rate-limiting step in testosterone synthesis because it is the transporter that moves cholesterol into the mitochondria, where steroidogenesis actually begins. Without adequate cholesterol delivery into the mitochondria, the production line stalls regardless of how much LH is arriving. Research by Maran and colleagues found that T3 induced a 260% increase in StAR protein expression in Leydig cells, which means your thyroid hormone is not just influencing the signal that reaches your testes, it is controlling how efficiently the factory inside your testes operates once the signal arrives.

The third mechanism involves something called SHBG, which stands for sex hormone binding globulin. Your liver produces SHBG and it binds to testosterone in circulation, rendering it biologically unavailable. Thyroid status influences how much SHBG your liver produces, which means two men with identical total testosterone numbers can have very different amounts of free, usable testosterone depending on their thyroid function. This is why total testosterone alone is not a sufficient number to act on, and why thyroid status has to be part of the interpretation.

All three mechanisms compound on each other. Suboptimal thyroid function weakens the pituitary signal, reduces Leydig cell sensitivity, impairs cholesterol delivery into steroidogenesis, and alters the binding protein that determines how much of the testosterone produced is actually available. A clinic that checks your testosterone, finds it low, and hands you a prescription without ever looking at thyroid function has addressed the symptom while leaving the cause untouched.

The same logic extends to growth hormone. Your pituitary contains cells called somatotrophs that release growth hormone in response to a signal from your hypothalamus, and those cells need adequate T3 to maintain the receptors that receive the signal. Miki and colleagues showed that hypothyroidism depressed the growth hormone response to GHRH and that T3 treatment restored it. This also affects the receptor that peptides like ipamorelin and MK-677 target directly. Kamegai and colleagues demonstrated in 2001 that T3 extends the half-life of the growth hormone secretagogue receptor's mRNA from 8 hours to 15 hours, effectively increasing receptor density in the pituitary. That study was conducted in rat pituitary cells, so it is not directly confirmed in humans, but the mechanism it describes is consistent with the broader pattern: thyroid hormone regulates how many receptors are available for the signals that drive growth hormone release, whether those signals come from your hypothalamus or from exogenous peptides.

This is the order of operations. Thyroid is upstream of testosterone, and thyroid is upstream of the growth hormone response. If you optimize or supplement the downstream systems while the upstream system is impaired, you are pushing against resistance that was addressable before any of the other decisions were made.

The bloodwork panel that captures this fully is TSH, free T3, free T4, and reverse T3. Alongside that, total testosterone, free testosterone, LH, and SHBG. TSH alone tells you whether the thermostat is set correctly. It does not tell you whether the heat is actually reaching the rooms.

If results show suboptimal conversion, meaning adequate free T4 but low free T3 or elevated reverse T3, there are addressable inputs before medication becomes the answer. Selenium at 200 micrograms per day supports the deiodinase enzymes responsible for T4 to T3 conversion, and should not exceed 400 micrograms. Zinc at 30 milligrams daily supports TRH synthesis and thyroid hormone receptor function. Iron is a component of thyroid peroxidase, the enzyme the thyroid gland itself needs to produce T4 and T3, and iron deficiency reduced TPO activity by 33 to 56% in controlled research, so ferritin levels are worth knowing. Iodine is the structural building block of both thyroid hormones, but excess iodine can worsen autoimmune thyroid conditions like Hashimoto's, so it only makes sense to supplement if deficiency has been confirmed. And cortisol management is not optional, because the diversion of T4 toward reverse T3 is not a slow process. It begins within hours of cortisol elevation and it creates functional hypothyroidism that no amount of selenium or iodine will correct.

When the thyroid panel shows true primary hypothyroidism with elevated TSH and low T4, those nutritional inputs are not sufficient. Hashimoto's thyroiditis, the most common cause of hypothyroidism, is autoimmune and requires medical management. Levothyroxine under physician supervision is appropriate in these cases, and over-replacement carries its own risks including bone loss, atrial fibrillation, and anxiety, which is why it requires ongoing monitoring rather than a one-time prescription.

The deeper point here is about what a number actually means. A low testosterone result tells you that testosterone is low. It does not tell you why. If the reason is that the pituitary relay is weakened by inadequate T3, and the Leydig cells are under-equipped because StAR protein expression is suppressed, then replacing testosterone addresses neither of those things. The foundation stays broken. The building just gets more floors added to it.

That is the whole point of checking upstream first.

---

References

1. Donnelly P, White C. 2000. Testicular dysfunction in men with primary hypothyroidism; reversal of hypogonadotrophic hypogonadism with replacement thyroxine. Clinical Endocrinology, 522:197-201. Free testosterone nearly doubled 161 to 315 pmol/L after thyroxine replacement in hypothyroid men. Source
2. Shrivastav A, Saboo B. 2022. Effect of levothyroxine replacement therapy on testosterone, LH, FSH levels in men with overt hypothyroidism. ECE2022 Conference Abstract, Endocrine Abstracts, 81, P730. 70% of hypogonadal hypothyroid patients had testosterone normalize after levothyroxine. Conference abstract, N=51. Source
3. Maran RR, et al. 2000. Assessment of mechanisms of thyroid hormone action in mouse Leydig cells. Endocrinology, 14112:4468-4477. T3 increases LH receptor numbers, StAR protein 260% increase, and steroidogenic enzyme expression in Leydig cells. Source
4. Kamegai J, et al. 2001. Thyroid hormones regulate pituitary growth hormone secretagogue receptor gene expression. Journal of Neuroendocrinology, 133:275-278. T3 increased GHS-R mRNA by extending half-life from 8h to 15h in rat pituitary cells. Source
5. Miki N, et al. 1989. Effects of hypothyroidism, T3 and glucocorticoids on GH responses to GHRH. Journal of Endocrinology, 122:585-591. Hypothyroidism depressed growth hormone response to GHRH; T3 treatment restored it. Source
6. Winther KH, et al. 2020. Thyroid function in patients with selenium deficiency exhibits high free T4 to T3 ratio. BMC Endocrine Disorders. Selenium deficiency directly associated with impaired T4 to T3 conversion. Source
7. Hess SY, et al. 2002. Iron deficiency anemia reduces thyroid peroxidase activity in rats. Journal of Nutrition, 1327:1951-1955. Iron deficiency reduced TPO activity by 33-56%. Source
8. Chopra IJ, et al. 1975. Opposite effects of dexamethasone on serum concentrations of reverse T3 and T3. Journal of Clinical Endocrinology and Metabolism. Cortisol shifts T4 metabolism toward reverse T3 within hours. Source

---

Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness